Articles On Alchemia (ASX:ACL)

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high level...

  US markets bounced back after three consecutive losing sessions & extended their first quarter advance. The S&P 500 closed at a new record high finishing the day up 0.86 per cent at 5,248. The Dow Jones closed up 1.2 per cent and...

US markets bounced back after three consecutive losing sessions & extended their first quarter advance. The S&P 500 closed at a new record high finishing the day up 0.86 per cent at 5,248. The Dow Jones closed up 1.2 per cent and th...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high level...

Cheaper homes and ASX small-cap shares are delivering superior capital growth to investors in 2024, new figures show. ASX small-cap shares are defined as companies with a market capitalisation of between a few hundred thousand and $2 bill...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high level...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high level...

It has been another busy day of earnings releases on Wednesday. Some results have gone down well with investors, others have not. For example, listed below are two ASX 300 shares that are being sold off following the release of their respe...

It's fair to say that ASX healthcare shares have flummoxed investors over the past couple of years. As interest rates headed up and consumers closed their wallets, many fund managers expected the health sector to outperform because of the...

After two years of shocking underperformance, ASX small-cap shares made a stunning comeback towards the end of 2023. "Despite the negativity that pervaded most of last year, the small cap market ultimately managed to deliver solid returns...

ASX healthcare share Australian Clinical Labs Ltd (ASX: ACL) has seen a large sell-off this year. So is this an opportunity to buy the dip? As we can see on the chart below, since March 2023, the Australian Clinical Labs share price has sh...

The nation’s privacy watchdog has launched civil proceedings against Australian Clinical Labs (ASX: ACL) over a Medlab hack that saw more than 223,000 patients and staff have their health records and credit card numbers stolen late last yea...

One of the biggest potential reasons for massive price movement in an ASX stock is mergers and acquisitions. That's because, in an instant, the nature of the whole business can change. If it's offloading an unprofitable activity, then the...

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.051% to 7068.80. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify...

Pilbara Minerals has become the most shorted ASX stock as price of lithium falls from 2022 highs Flight Centre the second most shorted ASX stock, despite a turnaround in its profits in FY23 AI play Brainchip Holdings booted from S&P AS...

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.46% to 7186.50. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify....

The ASX 200 climbed on Thursday Iron ore, uranium, and coal stocks mostly rallied Australian employment rate held steady in August, blowing past forecasts   Local shares climbed on Thursday as the labour market data blew past predictions....

The $1.58 billion off-market takeover bid for pathology company Healius (ASX: HLS) has been put on hold by Australian Clinical Labs (ASX: ACL) pending a decision by the competition watchdog and a review of the target’s FY23 financial statem...

  The Dow Jones Industrial Average fell Wednesday as traders absorbed a hotter-than-expected August core inflation print. The Dow lost 70.46 points, or 0.20 per cent, to 34,575.53 for its second straight decline. Meanwhile, the S&P 500...

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down 0.74% to 7153.90. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify...

The Healius Ltd (ASX: HLS) share price finished the session on Wednesday up 7.75% after the company released its full-year FY23 results. Healius reported an underlying profit of just $25.7 million, which is a 91.6% fall year over year. De...

It’s been a mildly pleasant day for the All Ordinaries Index (ASX: XAO) and most ASX All Ords shares so far today. This Tuesday has seen the All Ords add 0.1% at the time of writing. But let’s talk about three All Ords shares that aren’t f...

The Australian Competition and Consumer Commission (ACCC) is wary of the possible market impact if two of the country's largest pathology companies Australian Clinical Labs Limited (ASX: ACL) and Healius (ASX: HLS) join forces, particularly...

BPH Global about to ramp up China business ACL faces ACCC resistance on proposed takeover of Healius   BPH Global to expand China business Health & wellness stock BPH Global (ASX:BP8) rose 20% after flagging a potential ramp up in Chi...

The Australian Competition and Consumer Commission (ACCC) has dealt a blow to ACL’s (ACL) proposed acquisition of Healius (HLS), highlighting preliminary competition concerns over the merger. The ACCC released a statement of issues today...

If you’re on the lookout for bargain buys, then you may want to check out Australian Clinical Labs Ltd (ASX: ACL) shares. That’s because one fund manager believes the ASX 300 healthcare stock is trading at a mouth-watering discount. Th...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

A bid from Australian Clinical Labs (ASX: ACL) to merge with pathology services business Healius (ASX: HLS) has escalated into a slinging match, with the suitor now claiming the target is ‘failing’ shareholders by not recommending its $1.58...

There is an impression among many investors that big riches can only be achieved with ASX growth shares. But that can’t be further from the truth. There are multiple paths to the promised land. The fact is that strong returns are possible...

The ASX boards are home to hundreds of shares. And many of them pay out dividends to their investors every year. The relationship between the dividends per share that a company pays and the price that a company’s shares trade at produces t...

ShareCafeWeaker financial sector hits markets: Google and Alphabet rise afterhours                    Stocks slid Tuesday after First Republic Bank’s earnings report reignited concerns about the broader sector. Pressure on the sector...

The Australian Ethical Investment has divested its Lendlease holding The ESG-focused fundie explains why it invests in certain sectors The AEF also provides some ASX stock recommendations for ethical investors   ESG-focused fund manager A...

MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts to hear what’s hot, their top picks, and what they’re looking out for. Today we hear from Tribeca Inve...

There’s a little-known ASX All Ords share currently trading on a staggering 20% gross trailing dividend yield. This company is a small-cap among ASX healthcare shares with a market capitalisation of $712 million. It’s pathology services...

Healius (HLS) is dealt a blow as the Takeovers Panel decides against conducting proceedings over Australian Clinical Labs’ (ACL) off-market proposal last month Healius, Australia’s second-largest pathology provider, says there are “a num...

The conditions of a $1.58 billion bid from Australian Clinical Labs (ASX: ACL) are ‘overly restrictive and burdensome’ according to target Healius Limited (ASX: HLS), which has approached the Takeovers Panel for intervention in the matter....

ASX healthcare shares have underperformed the broader market since the pandemic-induced market lows in March 2020. Over the last three years, the S&P/ASX 200 Healthcare index has returned just 5.5% per year compared to the S&P/ASX 2...

Healius (HLS) reaffirms its “no action” stance to shareholders in relation to an off-market takeover bid from Australian Clinical Labs (ACL) on March 20 ACL says the merger, if it comes to fruition, could create Australia’s largest patho...

The ASX finished flattish on Monday Energy stocks lagged, while Utilities and Real Estate led There’s a host of key releases in Australia this week, including CPI data on Wednesday   The ASX 200 closed flattish on Monday with losses in th...

ShareCafeDeutsche Bank the latest international bank to tumble                    Stocks rose Friday after a volatile trading session. Although Friday began with fears that the banking crisis was spilling over to Deutsche Bank, the ma...

ASX health stocks fall 0.9% in the past five days Healius receives a $1.52 billion takeover offer from Australian Clinical Labs Pharmaceutical wholesaler Sigma reports improved performance for the financial year Healthcare and life scien...

The S&P/ASX 200 Index (ASX: XJO) is having a disappointing session on Thursday. In afternoon trade, the benchmark index is down 0.7% to 6,966.7 points. Four ASX shares that are not letting that hold them back are listed below. Here’...

ShareCafeASX closes 1.38% lower as investors digest Credit Suisse takeover by Peter Milios   On Monday, at the closing bell, the S&P/ASX 200 was 1.38 per cent lower at 6,898.50, as investors considered the takeover of Credit Suisse and...

Australian Clinical Labs has put an offer to Healius to swap shares in an off-market takeover offer. The post Healius [ASX:HLS] Receives Buyout Offer from ACL [ASX:ACL] appeared first on Money Morning Australia.

ASX accelerated losses in the afternoon, closing over 1% lower Healthcare stock Healius gets takeover bid from a much smaller company Market places 25% chance the Fed will pause this week   The ASX 200 index finished almost 1.5% lower on...

Australian Clinical Labs (ASX: ACL) has lobbed a $1.58 billion off-market offer to merge with one of its biggest competitors, Healius (ASX: HLS), as it looks to become the nation's largest pathology services provider and secure a deal that...

The S&P/ASX 200 Index (ASX: XJO) has started the week deep in the red. At the time of writing, the benchmark index is down 0.7% to 6,945.3 points. Four ASX shares that are not letting that hold them back today are listed below. Here’...

Healius gets takeover offer from ALC, a company more than half its size Neurotech will launch Phase 2 clinical trial in Rett Syndrome Germany allows Invex to commence the IIH EVOLVE Phase 3 clinical trial   Healius gets takeover offer fro...

The Healius Ltd (ASX: HLS) share price has jumped after receiving a takeover offer from Australian Clinical Labs Limited (ASX: ACL). Healius and ACL are two of the largest pathology businesses in Australia. Merger offer ACL announced this m...